Fahri Şahin
- Hematology top 5%
- Hemophilia Treatment and Research 13
- Chronic Myeloid Leukemia Treatments 13
- Acute Myeloid Leukemia Research 6
- Geriatrics and Gerontology top 5%
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 10
- Chronic Lymphocytic Leukemia Research 9
- Physiology top 10%
- Nephrology top 10%
-
- Lymphoma Diagnosis and Treatment 11
-
- Complement system in diseases 10
-
- Cytokine Signaling Pathways and Interactions 7
- Co-authors
- Güray SaydamYusuf BaranAsu Fergün YılmazSerdar Bedii OmayCumhur GündüzJ WüstBuket KosovaMarkus Vogt
- Journals
- SHILAP Revista de lepidopterología (7 papers)Blood (2 papers)Clinical Chemistry (1 paper)
- Partner nations
- TürkiyeUnited StatesItaly
In The Last Decade
Fahri Şahin
91 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 122
- Hematology 321
- Geriatrics and Gerontology 72
- Genetics 174
- Physiology 33
- Nephrology 50
Countries citing papers authored by Fahri Şahin
This map shows the geographic impact of Fahri Şahin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fahri Şahin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fahri Şahin more than expected).
Fields of papers citing papers by Fahri Şahin
This network shows the impact of papers produced by Fahri Şahin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fahri Şahin. The network helps show where Fahri Şahin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fahri Şahin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 39 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 17 | |
| 11 | 2019 | 2 | |
| 12 | 2017 | 4 | |
| 13 | 2017 | 3 | |
| 14 | 2015 | 20 | |
| 15 | 2015 | 19 | |
| 16 | Spontaneous Remission of Paroxysmal Nocturnal Hemoglobinuria During Eculizumab Treatment | 2014 | 2 |
| 17 | 2008 | 7 | |
| 18 | 2006 | 1 | |
| 19 | 2005 | 35 | |
| 20 | 2002 | 47 |
About Fahri Şahin
Fahri Şahin is a scholar working on Hematology, Genetics and Nephrology, having authored 102 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (13 papers), Chronic Myeloid Leukemia Treatments (13 papers), Lymphoma Diagnosis and Treatment (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Complement system in diseases (10 papers), Chronic Lymphocytic Leukemia Research (9 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Acute Myeloid Leukemia Research (6 papers). The work is most often cited by research in Hematology (321 citations), Geriatrics and Gerontology (72 citations) and Genetics (174 citations). Fahri Şahin has collaborated with scholars based in Türkiye, United States and Italy. Frequent co-authors include Güray Saydam, Yusuf Baran, Asu Fergün Yılmaz, Serdar Bedii Omay, Cumhur Gündüz, J Wüst, Buket Kosova, Markus Vogt, Christoph Kolling and Hikmet Hakan Aydın. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.